| abstract |
The invention relates to a solid pharmaceutical dosage form, containing asnActive ingredient with a diphosphonic acid or a physiologically acceptable salt thereofna dissolution rate of the pharmaceutical dosage form of at least 85%nafter 30 minutes, the active ingredient as granules, optionally together withnpharmaceutical excipients in the inner phase, and the outer phase asnLubricant less than 5 wt .-% stearic acid, based on the total weight of thenPharmaceutical form, contains. |